Gabrielle Lapping-Carr

Dr. Gabrielle Lapping-Carr

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2017 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr
AKAbdelnaby Khalyfa
Abdelnaby Khalyfa
SRStephanie Rangel
Stephanie Rangel
WDWendy Darlington
Wendy Darlington
Eric BeyerEric Beyer
Eric Beyer
DGDavid Gozal
David Gozal

26 May 2020 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr
JGJoanna Gemel
Joanna Gemel
Yifan MaoYifan Mao
Yifan Mao
GSGianna Sparks
Gianna Sparks
MHMargaret Harrington
Margaret Harrington
Eric BeyerEric Beyer
Eric Beyer

Verified
Journal Article
Open access
PDF file
JGJoanna Gemel
Joanna Gemel
Yifan MaoYifan Mao
Yifan Mao
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr
Eric BeyerEric Beyer
Eric Beyer
Intercellular junctions maintain the integrity of the endothelium. We previously found that the adherens and tight junctions between endothelial cells are disrupted by plasma extracellular vesicles from patients with sickle cell disease (especially those with Acute Chest Syndrome). In the current study, we evaluated the effects of these vesicles on endothelial gap junctions. The vesicles from sickle cell patients (isolated during episodes of Acute Chest Syndrome) disrupted gap junction structures earlier and more severely than the other classes of intercellular junctions (as detected by immunofluorescence). These vesicles were much more potent than those isolated at baseline from the same subject. The treatment of endothelial cells with these vesicles led to reduced levels of connexin43 mRNA and protein. These vesicles severely reduced intercellular communication (transfer of microinjected Neurobiotin). Our data suggest a hierarchy of progressive disruption of different intercellular connections between endothelial cells by circulating extracellular vesicles that may contribute to the pathophysiology of the endothelial disturbances in sickle cell disease.

3 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JGJoanna Gemel
Joanna Gemel
JZJared Zhang
Jared Zhang
Yifan MaoYifan Mao
Yifan Mao
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr
Eric BeyerEric Beyer
Eric Beyer
We previously found that the plasma of patients with sickle cell disease (SCD) contains large numbers of small extracellular vesicles (EVs) and that the EVs disrupt the integrity of endothelial cell monolayers (especially if obtained during episodes of acute chest syndrome, ACS). The present study was designed to test the generality of this finding to other complications of SCD, specifically to evaluate the possibility that circulating EVs isolated during a vaso-occlusive crises (VOC) also cause damage to the intercellular connections between endothelial cells. Plasma was obtained from nine pediatric subjects at baseline and during VOC episodes. EVs isolated from these samples were added to cultures of microvascular endothelial cells. Immunofluorescence microscopy was employed to assess monolayer integrity and to localize two intercellular junction proteins (VE-cadherin and connexin43). The EVs isolated during VOC caused significantly greater monolayer disruption than those isolated at baseline. The extent of disruption varied between different episodes of VOC or ACS in the same patient. The VOC EVs disrupted the integrity of both junction proteins at appositional membranes. These results suggest that circulating EVs may be involved in modulating endothelial integrity contributing to the pathogenesis of different complications of SCD.

13 June 2025 in Blood Advances
Verified
Journal Article
Open access
AWAustin Wesevich
Austin Wesevich
MWMegan Woelkers
Megan Woelkers
AAAyodeji Adegunsoye
Ayodeji Adegunsoye
AWAdam J. Wesevich
Adam J. Wesevich
MRMark J. Ratain
Mark J. Ratain
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr
Acute chest syndrome (ACS) severity is inconsistently defined, and its clinical course is difficult to predict. This retrospective observational study evaluated the utility of the ratio of pulse oximetry oxygen saturation (SaO2) to the fraction of inspired oxygen (SaO2/FiO2) in adult patients with ACS and its association with the clinical outcome of intensive care unit (ICU) transfer. Across all ACS hospitalizations at a tertiary medical center from 2017 to 2021, we characterized the SaO2/FiO2 ratio at 3 time points: emergency department (ED) presentation, ACS diagnosis, and antibiotic initiation. Of the 227 hospitalizations identified, 54% were female, the mean age was 29 years, 70% had hemoglobin SS, and 9% had obesity. Although ICU transfer was not strongly associated with the SaO2/FiO2 ratio at ED presentation (area under the curve [AUC], 0.59), it was strongly associated with the ratio at ACS diagnosis (AUC, 0.73) and antibiotic initiation (AUC, 0.74). Given the highest sensitivity at ACS diagnosis, a diagnostic SaO2/FiO2 cutoff of 310 was proposed for triaging likely ICU transfer (sensitivity, 63%; specificity, 82%; adjusted odds ratio, 8.94; 95% confidence interval [CI], 2.12-37.6; adjusted hazard ratio, 4.86; 95% CI, 1.91-12.4), with models adjusted for obesity, lung disease, and blood counts. This cutoff corresponds to an SaO2 acquired from pulse oximeter saturation <90% on 2 L/min nasal cannula support. We propose using the SaO2/FiO2 ratio cutoff of 310 prospectively as a simple bedside triage tool for adult patients with sickle cell disease hospitalized with ACS to be transferred to a higher level of care.

15 June 2015 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AGAlex Gileles-Hillel
Alex Gileles-Hillel
MPMona F. Philby
Mona F. Philby
GLGabrielle Lapping-Carr
Gabrielle Lapping-Carr